In 2024, the Biden administration proposed that Medicare cover GLP-1s for weight loss, but the Trump administration did not finalize that proposal
588,168 adults with type 2 diabetes: 139,546 started a GLP-1 drug 448,622 started an SGLT2 inhibitor Followed for up to 3 yearsAt 3 years, NAION was more frequent among people who started GLP-1 drugs: GLP-1 drugs: 39.1 cases per 10,000 persons SGLT2 inhibitors: 29.3 cases per 10,000 persons That works out to 6 to 10 extra cases per 10,000
Fried and greasy foods: Already harder to digest, these foods slow gastric emptying even further
By acting on both GIP and GLP-1 signals, tirzepatide works through an additional appetite and blood-sugar pathway
This product may expose you to chemicals, including lead, known to the State of California to cause birth defects or reproductive harm